Ferriprox and Aranesp drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ferriprox (deferiprone) and Aranesp (darbepoetin alfa). Common drug interactions include death among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Ferriprox and Aranesp. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Ferriprox?

Ferriprox has active ingredients of deferiprone. eHealthMe is studying from 1,991 Ferriprox users. Check the latest studies of Ferriprox.

What is Aranesp?

Aranesp has active ingredients of darbepoetin alfa. It is often used in anemia. eHealthMe is studying from 54,331 Aranesp users. Check the latest studies of Aranesp.

On Jul, 15, 2026

31 people who take Ferriprox and Aranesp together, and have interactions are studied.

Ferriprox and Aranesp drug interactions.

What are the common drug interactions of Ferriprox and Aranesp, by gender? *:

female:

Death
Pain in extremity
Vomiting
Nausea (feeling of having an urge to vomit)
Thrombocytopenia (decrease of platelets in blood)
Abdominal distension
Ascites (accumulation of fluid in the abdominal cavity)
Cardiac failure congestive
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Hypoglycaemia (deficiency of glucose in the bloodstream)

male:

Death
Hepatic enzyme increased
Viral infection
Vomiting
Abdominal pain
Arthritis infective (purulent invasion of a joint by an infectious agent which produces arthritis)
Dysphagia (a condition in which swallowing is difficult or painful)
Pyrexia (fever)
Renal failure (kidney dysfunction)
Surgery

What are the common drug interactions of Ferriprox and Aranesp, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Abdominal distension
Ascites (accumulation of fluid in the abdominal cavity)
Hypoglycaemia (deficiency of glucose in the bloodstream)
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Immunodeficiency
Nausea (feeling of having an urge to vomit)
Pancreatic atrophy
Pyrexia (fever)
Staphylococcus test positive
Urinary tract infection

10-19:

Hepatic enzyme increased

20-29:

Headache (pain in head)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

30-39:

n/a

40-49:

Renal failure (kidney dysfunction)

50-59:

Thrombocytopenia (decrease of platelets in blood)
Death
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Neutropenia (an abnormally low number of neutrophils)
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Diarrhoea
Vomiting
Bone marrow failure
Cytogenetic abnormality
Haematoma (collection of blood outside the blood vessels)

60+:

Death
Pain in extremity
Cardiac failure congestive
Constipation
Thrombosis (formation of a blood clot inside a blood vessel)
Arthritis infective (purulent invasion of a joint by an infectious agent which produces arthritis)
Escherichia infection (bacterial infection by escherichia coli)
Surgery
Dizziness
Neutropenia (an abnormally low number of neutrophils)

What are the existing conditions these people have? *

Haemochromatosis (body to absorb more iron than usual from food): 23 people, 74.19%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 7 people, 22.58%
Refractory Anaemia With An Excess Of Blasts (one or more cell types are low in the blood and look abnormal in the bone marrow): 2 people, 6.45%
Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 6.45%
Iron Overload: 2 people, 6.45%
Anaemia (lack of blood): 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Ferriprox and Aranesp?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously